Sotera Health Company Common Stock vs Xylem, Inc. — how do they compare? Sotera Health Company Common Stock trades at $17.75 (market cap $5.06B), while Xylem, Inc. trades at $103.54 (market cap $23.99B). The key difference: Xylem, Inc. is far larger — about 4.7× Sotera Health Company Common Stock's market cap, and Xylem, Inc. pays a 1.67% dividend while Sotera Health Company Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sotera Health Company Common Stock for 0 Days and Xylem, Inc. for 51 Days on average.
| SHC | XYL | |
|---|---|---|
Market Cap | $5.06B | $23.99B |
Volume | 2,279,715 | 2,429,384 |
Sector | Health | Industrials |
52-Week High | $19.57 | $152.95 |
52-Week Low | $13.13 | $100.92 |
Typical Hold Time | 0 Days | 51 Days |
Enterprise Value | $6.97B | $25.77B |
Dividend Yield | — | 1.67% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Xylem (XYL) trades at $102.54, down slightly by 0.05% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.46 surpassing the $1.35 estimate. Revenue grew to $9.04 billion in 2025, and net income margin improved to 10.59%. Recent developments include a $1.5 billion senior note offering to fund acquisitions and the appointment of a new CFO.
The outlook for XYL is supported by steady revenue growth, margin expansion, and strategic acquisitions in water technology, though near-term technical weakness and China-related headwinds pose risks. Analyst consensus is mixed with a $146.63 price target implying significant upside, but investors should monitor execution on acquisitions and debt levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Sotera Health Company is a US provider of sterilization and lab testing services for the healthcare industry, operating through its Sterigenics, Nordion, and Nelson Labs businesses.
Read more on SHC →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →